·   Log in

‘Featured’ News

Glenmark cuts back drug discovery spend

Thursday, October 29, 2009 15:37

At least 3 of Glenmark lead molecules failed or got suspended in mid-stage trials in the recent months

Tagged with:

Wockhardt denies sell-out talks with Pfizer on biotech business

Thursday, October 29, 2009 11:21

Indian generic firm Wockhardt has denied press reports of a possible sell-out of its biotech business to the world’s largest drug maker Pfizer.

Tagged with:

Purdue Pharma sues Ranbaxy on generic OxyContin (oxycondone) patent rights in US

Tuesday, October 27, 2009 12:02

OxyContin was the ninth most-selling drug in the US in 2008 with sales of $2.5 billion

Sun Pharma resolves lawsuit on adamantane (Namenda) with Forest Labs; won’t market Alzheimer’s drug till patent expiry

Thursday, October 22, 2009 19:34

Sun Pharma had settled a similar patent dispute with Forest on Lexapro in July

DCGI’s drug licence centralizing plan suffers another blow as Karnataka High Court stays order

Wednesday, October 21, 2009 17:28

DCGI's directive to issue CoPP only through CDSCO has already been stayed by 2 high court orders

Natco Pharma denies legal action from DCGI for marketing ’sub-standard’ breast cancer drug Albupax

Tuesday, October 20, 2009 14:31

Reports of DCGI's criminal proceedings is a malicious campaign by rival firm, alleges Natco

India’s API exports to Europe reach over 27%: Pharmexcil

Monday, October 19, 2009 16:44

Indian pharma exporters secure the highest number - 31% - of manufacturing quality certificates (CEPs) granted by EDQM during January – July 2009

Tagged with: , , ,

Centralized drug licensing in jeopardy as Indian court stays DCGI’s order

Thursday, October 15, 2009 21:44

A regional Indian High Court has issued an injunction staying an order that aimed to restrict issuance of product manufacturing licences by state drug agencies, throwing a spanner on the central drug authority's efforts to streamline the licensing practices to ensure quality of drug products manufactured across the country.

Merck KGaA buys out Indian bio services firm Bangalore Genei

Tuesday, October 13, 2009 9:04

Bangalore Genei's leadership in academic segment expects to boost Merck's bio business in India

Bulk drug manufacturing in India to go green; Eco-norms will cover more small scale API producers

Thursday, October 8, 2009 12:49

Pharmaceutical manufacturing, especially in the more chemical effluents creating bulk drug production plants in India may become environment-friendly soon.